MileCell to Exhibit at JSOT 2026 in Osaka

MileCell Biotechnology is pleased to announce our participation in The 53rd Annual Meeting of the Japanese Society of Toxicology (JSOT 2026), taking place from July 1–3, 2026, at the Osaka International Convention Center, Japan.

As one of Japan’s leading meetings in toxicology and safety sciences, JSOT provides an important platform for researchers, industry professionals, and regulatory experts to exchange insights on the latest advances in toxicological sciences, safety assessment, in vitro models, and emerging methodologies.

The theme of JSOT 2026, “Evolving Toxicology – Innovation Emerging from the Confluence of Diverse Fields,” highlights the growing importance of interdisciplinary collaboration in shaping the future of toxicology and safety evaluation.

At MileCell, we are committed to supporting more predictive, reproducible, and biologically relevant ADME/Tox and preclinical research. During JSOT 2026, we will showcase our high-quality biological systems and in vitro research tools designed to support drug metabolism, safety assessment, genotoxicity evaluation, and translational preclinical workflows.

Our featured solutions include:

* Primary hepatocytes from multiple species
* Liver non-parenchymal cells
* Liver and intestine microsomes
* Induced S9 fractions and other subcellular fractions
* ADME/Tox-related biological materials and culture reagents

With reliable biological materials and fit-for-purpose in vitro models, MileCell aims to help researchers generate consistent, reproducible, and biologically relevant data across drug discovery and safety assessment programs.

Visit MileCell at JSOT 2026

Event: The 53rd Annual Meeting of the Japanese Society of Toxicology
Date: July 1–3, 2026
Venue: Osaka International Convention Center, Japan
Booth: #83

We look forward to meeting scientists, partners, and industry colleagues in Osaka to discuss how MileCell can support your ADME/Tox, toxicology, and preclinical development research.